The groundbreaking therapy of the medication represents a significant advance in the management of the condition. Different to existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment